Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
6 March 2017
European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access
Financial News
21 March 2017
Notification for signed annex to the Contract for transformation through merger of Medica AD in Sopharma AD
9 March 2017
Notification
7 March 2017
Sales revenues for the first two months of 2017
Financial Highlights 31 December 2015
874,984
BGN '000 Revenue
66,766
BGN '000 EBITDA
36,440
BGN '000 Revenue from operating profit
22,600
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
30 March 2017
Individual audited financial statements for 2016
5 April 2017
Financial revenues for January-March 2017

Equity story

80+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A